SCHEMBL163350

SCHEMBL163350

CN[C@@H](CO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170982 1.00 — —
SCHEMBL181375 1.00 — —
Hydrochloric Acid SCHEMBL28497287 0.97 — —
SCHEMBL790222 0.97 — —
Water SCHEMBL27785467 0.97 — —
Hydrochloric Acid SCHEMBL2852741 0.97 — —
Hydrochloric Acid SCHEMBL2852737 0.97 — —
Hydrochloric Acid SCHEMBL27763690 0.95 TGFBR1 (0.47) —
Formic Acid SCHEMBL28393660 0.91 TGFBR1 (0.44) —
Serine SCHEMBL16397814 0.87 TGFBR1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4579 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746912-A1 ORGANIC CYTOTOXIN OLIGOMERS AND USES THEREOF AS A PAYLOAD IN ANTIBODY-DRUG CONJUGATES Simris Biologics GmbH (DE) 2026-05-27 — — EP claimed
EP-4743120-A1 MOLECULAR DEGRADERS FOR THE TREATMENT OF IGA NEPHROPATHY Biohaven Therapeutics Ltd. (VG) 2026-05-20 — — EP claimed
EP-4745237-A1 RNAI AGENT FOR INHIBITING EXPRESSION OF KETOHEXOKINASE AND USE THEREOF YUN HO BIO CO., LTD (CN) 2026-05-20 — — EP claimed
CN-122070296-A Insect neuropeptide analogs 索拉斯塔生物有限公司 2026-05-19 — — CN claimed
CN-116457073-B Solvent solution and method KC8捕集技术有限公司 2026-05-15 — — CN claimed
CN-122028793-A Fungicidal compositions 先正达农作物保护股份公司 2026-05-12 — — CN claimed
EP-4727654-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 — — EP claimed
EP-4727655-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 — — EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 — — EP claimed
EP-1069906-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTRATE CANCER Merck & Co., Inc. (US) 2001-01-24 — — EP claimed
WO-1999044628-A1 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO., INC. (US) 1999-09-10 — — WO claimed
EP-0813544-A4 — — 1998-01-07 — — EP claimed
EP-0813544-A1 BRADYKININ ANTAGONIST PEPTIDES INCORPORATING N-SUBSTITUTED GLYCINES CORTECH, INC. (US) 1997-12-29 — — EP claimed
US-5565493-A ADMINISTERING N-METHYL-L-SERINE KANEBO, LTD. (JP) 1996-10-15 — — US claimed
WO-1995029691-A1 PROLINE PHOSPHONATE DERIVATIVES GEORGIA TECH RESEARCH CORPORATION (US) 1995-11-09 — — WO claimed
WO-1995024422-A1 BRADYKININ ANTAGONIST PEPTIDES INCORPORATING N-SUBSTITUTED GLYCINES CORTECH, INC. (US) 1995-09-14 — — WO claimed
EP-0506965-B1 COLLAGEN METABOLISM AMELIORANT AND ITS USE KANEBO LTD (JP) 1995-06-28 — — EP claimed
US-5332758-A N-methylserine KANEBO, LTD. (JP) 1994-07-26 — — US claimed
EP-0506965-A1 COLLAGEN METABOLISM AMELIORANT AND ITS USE KANEBO LTD. (JP) 1992-10-07 — — EP claimed
Send feedback